Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta.
- Published in:
- Integrative Biology, 2020, v. 12, n. 7, p. 188, doi. 10.1093/intbio/zyaa014
- By:
- Publication type:
- Article
Works matching IS 17579694 AND DT 2020 AND VI 12 AND IP 7
Results: 2
1
2
Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.
- Published in:
- Integrative Biology, 2020, v. 12, n. 7, p. 175, doi. 10.1093/intbio/zyaa013
- By:
- Publication type:
- Article